MEDIFAST

MEDIFAST

Yahoo Finance • 2 days ago

Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?

Medifast, Inc. MED is advancing its strategic transition toward metabolic health, with management expecting positive trends to continue through the remainder of the year. The launch of its new consumer brand, Trilivy, marks the first step... Full story

Yahoo Finance • 3 days ago

All You Need to Know About Medifast (MED) Rating Upgrade to Buy

Medifast (MED) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The... Full story

Yahoo Finance • 7 days ago

3 Reasons to Sell MED and 1 Stock to Buy Instead

3 Reasons to Sell MED and 1 Stock to Buy Instead Medifast trades at $11.62 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P 500 has returned 12.7%. Is there... Full story

Yahoo Finance • 24 days ago

Bullish Two Hundred Day Moving Average Cross - MED

In trading on Tuesday, shares of Medifast Inc (Symbol: MED) crossed above their 200 day moving average of $11.20, changing hands as high as $13.44 per share. Medifast Inc shares are currently trading up about 37.2% on the day. The chart... Full story

Yahoo Finance • 25 days ago

Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues

Earnings Call Insights: Medifast (MED) Q2 2026 MANAGEMENT VIEW * CEO & President Nicholas Johnson said Q2 continued “positive indicators,” highlighting that “revenue has stabilized sequentially over the recent quarters, aided by higher... Full story

Yahoo Finance • last month

Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026

BALTIMORE, July 20, 2026--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended J... Full story

Yahoo Finance • last month

3 Unpopular Stocks That Concern Us

3 Unpopular Stocks That Concern Us Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps deliv... Full story

Yahoo Finance • 3 months ago

Stocks to watch on Tuesday after-hours: ZS, MED, FLY

[Stock market activity shows price changes and trading movements in real time] FabrikaCr Wall Street’s major market averages finished mostly higher on Tuesday as investors assessed the possibility of a resolution in the U.S.-Iran conflict... Full story

Yahoo Finance • 3 months ago

The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do

A randomized controlled trial published in Obesity Science & Practice found that clients on the OPTAVIA Optimal Weight 5 & 1 Plan® who worked with a coach lost significantly more weight and fat than those who attempted the program without... Full story

Yahoo Finance • 3 months ago

Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes

70% of users discontinued use of lifestyle behavior and health apps within the first 100 days (Kidman PG, et al., 2024)Early weight loss at week four is a strong predictor of clinically relevant outcomes, with research identifying addition... Full story

Yahoo Finance • 3 months ago

Peer-Reviewed Research Is Redefining Weight Loss Program Standards

The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the categoryRandomized controlled trials control for the lifestyle variables and selection... Full story

Yahoo Finance • 3 months ago

Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation

Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al., 2019)Structured plans, habit building, and dedicated coach support work together to produce body com... Full story

Yahoo Finance • 4 months ago

Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026

Earnings Call Insights: Medifast (MED) Q1 2026 MANAGEMENT VIEW * "We are seeing further evidence that our business is at the beginning of a period of stabilization and that we are making meaningful progress in delivering tangible tract... Full story

Yahoo Finance • 4 months ago

Medifast Q1 2026 Earnings Preview

* Medifast (MED [https://seekingalpha.com/symbol/MED]) is scheduled to announce Q1 earnings results on Monday, May 4th, after market close. * The consensus EPS Estimate is -$0.52 [https://seekingalpha.com/symbol/MED/earnings/estimates]... Full story

Yahoo Finance • 5 months ago

Personal Care Stocks Q4 In Review: Coty (NYSE:COTY) Vs Peers

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Coty (NYSE:COTY) and its peers. While personal care products products may seem more discretionary than food,... Full story

Yahoo Finance • 5 months ago

3 Consumer Stocks That Concern Us

Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. Surprisingly, the sector hasn’t played its shielding role over the past six months as it tumbled 5.5%. This drawdown was worse than the S&P 500’s... Full story

Yahoo Finance • 5 months ago

We Think MEDICLIN's (ETR:MED) Solid Earnings Are Understated

MEDICLIN Aktiengesellschaft's (ETR:MED) recent earnings report didn't offer any surprises, with the shares unchanged over the last week. We did some analysis to find out why and believe that investors might be missing some encouraging fact... Full story

Yahoo Finance • 5 months ago

Monday 3/30 Insider Buying Report: CDNL, MED

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is... Full story

Yahoo Finance • 6 months ago

Medifast outlines $270M–$300M 2026 revenue target as CEO transition and metabolic health focus drive execution

Earnings Call Insights: Medifast (MED) Q4 2025 MANAGEMENT VIEW * Daniel Chard, Executive Chairman & CEO, announced his intention to step down as CEO effective June 1, 2026, stating "I've led this company for close to 10 years now... Th... Full story

Yahoo Finance • 6 months ago

Medifast (MED) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Date Tuesday, Feb. 17, 2026 at 4:30 p.m. ET Call participants Chairman and Chief Executive Officer — Daniel R. ChardPresident — Nicholas M. JohnsonChief Financial Officer — James P. Maloney Takeaways CE... Full story